-+ 0.00%
-+ 0.00%
-+ 0.00%

*Veradermics on Track to Deliver Topline Data From Phase 2/3 Study '306' Evaluating VDPHL01 in Female Pattern Hair Loss in 1H27 >MANE

Dow Jones·11/10/2026 12:34:00

Please log in to view news